System and Method for In Situ Visualization of Nerves Using Targeted Flourescent Molecules
The present invention is directed to a system and method for enhancing in situ visualization of a target site within a patient during a medical procedure using fluorescence. As such, the system includes a plurality of fluorescent molecules configured to selectively target and bind to one or more locations at the target site within the patient and a delivery mechanism for delivering the fluorescent molecules into the patient. In addition, the system includes a detection device configured to generate a detectable signal containing information relating to the target site and send the detectable signal to an imaging system for viewing by a user, such as a physician. Thus, the fluorescent molecules enhance in situ visualization of the target site when viewed through the skin of the patient.
1 . A system for enhancing in situ visualization of a target site within a patient during a medical procedure, the system comprising:
a plurality of fluorescent molecules configured to selectively target and bind to one or more locations at the target site within the patient;
a delivery mechanism for delivering the plurality of fluorescent molecules into the patient towards the target site; and,
a detection device comprising a light source, the detection device configured to:
generate a detectable signal comprising information relating to the target site, and
send the detectable signal to an imaging system, wherein the light source illuminate the fluorescent molecules so as to enhance in situ visualization of the target site when viewed through the skin of the patient.
2 . The system of claim 1 , wherein the detection device further comprises at least one sensor comprising an emitter and a receiver.
3 . The system of claim 2 , wherein the sensor comprises a fiber optic sensor.
4 . The system of claim 1 , wherein each of the fluorescent molecules comprises a diameter of from about 1 nanometer to about 100 nanometers.
5 . The system of claim 1 , wherein the fluorescent molecules are suspended in a liquid medium in a quantity of from about one thousand (1,000) to about one million (1,000,000) fluorescent molecules.
6 . The system of claim 5 , wherein the liquid medium is delivered, via the delivery mechanism, to the target site via a plurality of phages.
7 . The system of claim 1 , wherein the delivery mechanism comprises at least one of a needle or a syringe.
8 . The system of claim 1 , wherein each of the plurality of fluorescent molecules comprises at least one of a fluorescent moiety, a fluorescent protein, a peptide, or a fluorescent dye.
9 . The system of claim 1 , wherein the plurality of fluorescent molecules temporarily bind to the one or more locations at the target site for a predetermined dwell time before diffusing into the patient, wherein the predetermined dwell time of the plurality of fluorescent molecules comprises from about one day to about two days.
10 . The system of claim 1 , wherein the target site of the patient comprises at least one of nerve cells, cancer cells, nerve sheaths, nerve bundles, or nerve fibers.
11 . The system of claim 1 , wherein the medical procedure comprises a peripheral nerve block procedure.
12 . The system of claim 1 , wherein the imaging system comprises at least one of a CT scanner, an MRI scanner, or an ultrasound imaging system, the imaging system comprising a display for viewing the target site, wherein the fluorescent molecules echogenically enhance the target site when viewed by the display.
13 . A method for detecting a target site within a patient through the patient's skin during a medical procedure, the method comprising:
delivering, via a delivery mechanism, a plurality of fluorescent molecules into the patient towards the target site;
allowing the plurality of fluorescent molecules to selectively target and bind to the target site; and,
once the plurality of fluorescent molecules have bound to the target site, viewing the target site of the patient through the patient's skin.
14 . The method of claim 13 , wherein delivering the plurality of fluorescent molecules into the patient towards the target site further comprises suspending the plurality of fluorescent molecules in a liquid medium and delivering the liquid medium to the target site via a plurality of phages.
15 . The method of claim 13 , further comprising adjusting a quantity of the fluorescent molecules being delivered into the patient as a function of the medical procedure.
16 . The method of claim 13 , further comprising viewing the target site of the patient through the patient's skin via a detection device that generates a detectable signal containing information related to the target site and sends the detectable signal to an imaging system.
17 . The method of claim 16 , wherein the detection device further comprises at least one sensor comprising an emitter and a receiver, and wherein the sensor comprises a fiber optic sensor.
18 . The method of claim 13 , wherein each of the plurality of fluorescent molecules comprises at least one of a fluorescent moiety, a fluorescent protein, a peptide, or a fluorescent dye.
19 . The method of claim 13 , wherein the target site of the patient comprises at least one of nerve cells, cancer cells, nerve sheaths, nerve bundles, or nerve fibers, and wherein the medical procedure comprises a peripheral nerve block procedure.
20 . The method of claim 13 , wherein the imaging system comprises at least one of a CT scanner, an MRI scanner, or an ultrasound imaging system, the imaging system comprising a display for viewing the target site, wherein the fluorescent molecules echogenically enhance the target site when viewed by the display.